PTC Therapeutics, Inc. (PTCT) Operating cash flow 2016–2025
PTC Therapeutics, Inc. (PTCT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$711.2MFY2025 · since FY2016: -$103.6M → $711.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $711.2M | +760.4% |
| FY2024 | -$107.7M | +32.0% |
| FY2023 | -$158.4M | +55.6% |
| FY2022 | -$356.7M | -41.9% |
| FY2021 | -$251.3M | -29.5% |
| FY2020 | -$194.1M | -96.7% |
| FY2019 | -$98.6M | -256.9% |
| FY2018 | -$27.6M | -174.7% |
| FY2017 | -$10.1M | +90.3% |
| FY2016 | -$103.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice